Filing Details
- Accession Number:
- 0001593968-24-000449
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-06 21:52:06
- Reporting Period:
- 2024-01-30
- Accepted Time:
- 2024-03-06 21:52:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1737287 | Allogene Therapeutics Inc. | ALLO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491874 | M. Geoffrey Parker | 210 East Grand Ave South San Francisco 94080 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-30 | 190 | $3.60 | 819,590 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Mr. Parker was notified by his broker on March 4, 2024 that these shares were purchased in an account held by the Geoffrey M. Parker and Jill G. Parker Rev. Trust dated January 27, 2000 for which Mr. Parker does not have discretion. This account is intended to closely track the performance of the Russell 2000 and is frequently rebalanced by an algorithm designed by the broker which led to the purchase of these shares. Restrictions have been now placed on all such accounts held by the Trust to avoid such purchases of the Issuer stock in the future.
Billionaire Hedge Funds
